Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Coca-Cola Consolidated, Inc.Coca-Cola Consolidated Reports 10.6% Revenue Growth in Q2 2026 Despite Decline in Net Income
Symbotic Inc.Symbotic Inc. Reports 22% Revenue Growth to $720.8 Million in Latest Quarter
Adient plcAdient Reports 5% Revenue Growth to $3.93 Billion in Q3 Fiscal 2026
Dave Inc./DEDave Inc. Reports 30% Revenue Growth to $170.8 Million in Latest Quarter
Apple Hospitality REIT, Inc.Apple Hospitality REIT Reports 4.7% Revenue Growth in Q2 2026
LABCORP HOLDINGS INC.Labcorp Reports 5.8% Revenue Growth to $3.731 Billion in Q2 2026
Block, Inc.Block, Inc. Reports $6.62 Billion Revenue in Q2 2026 Amid Restructuring and Bitcoin Losses
RxSight, Inc.RxSight Reports Q2 2026 Revenue of $33.7 Million, Faces Decline in Product Sales
Enliven Therapeutics, Inc.Enliven Therapeutics Reports $32.5 Million Net Loss in Q2 2026, Increases Cash Reserves to $895.2 Million
STAR GROUP, L.P.Star Group Reports Q3 Net Loss of $27.99 Million, Sales Increase 16.5%
DHI GROUP, INC.DHI Group Reports $31.3 Million Revenue in Q2 2026, Net Income Improves to $2.6 Million
CHIMERA INVESTMENT CORPChimera Investment Corporation Reports Q2 2026 Financial Results with $4 Million Net Loss
Vaxcyte, Inc.Vaxcyte Reports $284.3 Million Net Loss in Q2 2026, Driven by Increased R&D Expenses
Sinclair, Inc.Sinclair Reports 7.1% Revenue Increase to $840 Million in Q2 2026
ZIPRECRUITER, INC.ZipRecruiter Reports 5% Revenue Growth and Significant Net Income Turnaround in Q2 2026
Kraft Heinz CoKraft Heinz Reports $5.46 Billion Net Loss in Q2 2026, Improved from Last Year
Zevia PBCZevia Reports 1.1% Net Sales Increase to $45M in Q2 2026, Faces $2.9M Net Loss
TTM TECHNOLOGIES INCTTM Technologies Reports 37.4% Revenue Growth to $1.004 Billion in Latest Quarter
ALLIENT INCAllient Inc. Reports 10% Revenue Growth to $153.8 Million in Q2 2026
BLACKLINE, INC.BlackLine Reports 9% Revenue Growth to $187.8 Million in Q2 2026
agilon health, inc.Agilon Health Reports 7% Revenue Growth to $1.5 Billion in Q2 2026
CARLSMED, INC.Carlsmed Reports 57% Revenue Growth to $18.9 Million in Latest Quarter
Arcus Biosciences, Inc.Arcus Biosciences Reports 74% Revenue Decline in Q2 2026, Net Loss of $91 Million
Revolution Medicines, Inc.Revolution Medicines Reports $644.4M Net Loss in Q2 2026, Driven by Increased R&D Expenses
STANDARD BIOTOOLS INC.Standard BioTools Reports Q2 2026 Financial Results with Revenue Decline and Net Loss